First human test of AstraZeneca's obesity pill
NCT ID NCT06942923
Summary
This was a small, early-stage study to check if a new oral drug called AZD4144 is safe for people with obesity. Twenty-eight healthy adults with obesity took the drug or a placebo daily for up to 28 days. Researchers primarily looked for side effects and measured changes in blood markers related to inflammation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Berlin, 14050, Germany
Conditions
Explore the condition pages connected to this study.